Scientific Online Resource System

Scripta Scientifica Medica

PYOGENIC LIVER ABSCESS - ETIOLOGICAL SPECTRUM AND SENSITIVITY TO ANTIBIOTICS

Atanas Iliev Lisnichkov, Milena Bozhkova, Temenuga Stoeva, Vassil Bozhkov, Ilko Plachkov, Plamen Chernopolski, Todor Ivanov, Gergana Nedelcheva, Viktoriya Snegarova, Dobromira Dimitrova, Rossen Madjov

Abstract

Introduction: Pyogenic liver abscess (PLA) is a serious challenge in modern medical practice. The aim of this study was to investigate the etiology and antimicrobial susceptibility of PLA-associated microbial pathogens, diagnosed in hospitalized patients at St. Marina University Hospital of Varna during the period between 2001 and 2016.

Materials and Methods: A total of 84 clinical samples (pus aspirates, n=72, bile samples, n=7, and blood cultures, n=5), collected from PLA patients, hospitalized in the Second Surgery Clinic were analyzed. Species identification was performed by conventional methods. Antimicrobial susceptibility was studied by disk diffusion method and Phoenix 100 (BD). The results were interpreted according to CLSI and EUCAST standards.

Results: Causative bacterial agents belonging to 15 different species were isolated in 59 cases (in 70%). E. coli (23.7%), K. pneumoniae (20%), E. cloacae (13.5%), E. faecalis (8.5%), P. mirabilis (5%) and P. aeruginosa (5%) dominated in the etiological spectrum. E. coli demonstrated the following levels of antimicrobial susceptibility: imipenem, amikacin, piperacillin/tazobactam, 100%; ceftazidime, cefepime, 90.9%; cefuroxime, 83.3%; amoxicillin/clavulanic acid, 77.8%; gentamicin, 75%; levofloxacin, cefalothin, 66.6%; ciprofloxacin, 63.6%; piperacillin, 58.3%; ampicillin, 45.5%. The following antimicrobial susceptibility rates were determined for K. pneumoniae: imipenem, 100%; amikacin, 92.3%; ceftazidime, cefepime, 80%; cefalothin, cefuroxime, 75%; levofloxacin, gentamicin, 66.6%; ciprofloxacin, 62.5%; piperacillin/tazobactam, 57.1%; piperacillin, 25% and amoxicillin/clavulanic acid, 22.2%.

Conclusions: E. coli and K. pneumonia are the predominant pathogens in PLA patients. Carbapenems are the most active antimicrobial agents followed by ceftazidime and cefepime. In the aminoglycoside group, amikacin demonstrates the best in vitro activity.


Keywords

pyogenic liver abscess, E. coli, K. pneumoniaе, antibacterial agents, resistance

Full Text


References

Law ST, Li KK. Is hepatic neoplasm-related pyogenic liver abscess a distinct clinical entity? World J Gastroenterol. 2012;18(10):1110-6. doi: 10.3748/wjg.v18.i10.1110.

Madjov R, Arnaudov P, Bozhkov V. Pyogenic liver abscess. Diagnostic and therapeutic strategy. In: 12th National Surgical Congress. Sofia, October 5-8.X.2006. Proceedings, 127-131.

Ivanov K. Diagnosis and treatment of liver abscesses. In: 12th National Surgical Congress. Sofia, October 5-8.X.2006. Proceedings, 116-119.

Czerwonko ME, Huespe P, Bertone S, Pellegrini P, Mazza O, Pekolj J, et al. Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. HPB (Oxford). 2016;18(12):1023-30. doi: 10.1016/j.hpb.2016.09.001.

Hernández JL, Ramos C. Pyogenic hepatic abscess: clues for diagnosis in the emergency room. Clin Microbiol Infect. 2001;7(10):567-70.

O`Farrell N, Collins CG, McEntee GP. Pyogenic liver abscesses: diminished role for operative treatment. Surgeon. 2010;8(4):192-6. doi: 10.1016/j.surge.2010.01.001.

Pearce NW, Knight R, Irving H, Menon K, Prasad KR, Pollard SG, et al. Non-operative management of pyogenic liver abscess. HPB (Oxford). 2003;5(2):91-5. doi: 10.1080/13651820310001126.

Chen SC, Yen CH, Lai KC, Tsao SM, Cheng KS, Chen CC, et al. Pyogenic liver abscesses with Escherichia coli: etiology, clinicalcourse, outcome, and prognostic factors. Wien Klin Wochenschr. 2005;117(23-24):809-15.

Liu L, Chen W, Lu X, Zhang K, Zhu C. Pyogenic liver abscess: a retrospective study of 105 casesinan emergency department from East China. J Emerg Med. 2017;52(4):409-16. doi: 10.1016/j.jemermed.2016.09.026.

Pastagia M, Arumugam V. Klebsiella pneumoniae liver abscesses in a public hospital in Queens, New York. Travel Med Infect Dis. 2008;6(4):228-33. doi: 10.1016/j.tmaid.2008.02.005.

Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004;39(11):1654-9.

Lübbert C, Wiegand J, Karlas T. Therapy of liver abscesses. Viszeralmedizin. 2014;30(5):334-41. doi: 10.1159/000366579.

Yang CC, Yen CH, Ho MW, Wang JH. Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae. J Int Med Res. 2013;41(4):1088-97. doi: 10.1177/0300060513487645.

Hu BS, Lau YJ, Shi ZY, Lin YH. Necrotizing fasciitis associated with Klebsiella pneumoniae liver abscess. Clin Infect Dis. 1999;29(5):1360-1.

Pichler C, Büchsel M, Rossen JW, Vavra M, Reuter S, Kern WV, et al. First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016. New Microbes New Infect. 2017;17:77-80. doi: 10.1016/j.nmni.2017.02.006.

Saccente M. Klebsiella pneumoniae liver abscess, endophthalmitis, and meningitis in a man with newly recognized diabetes mellitus. Clin Infect Dis. 1999;29(6):1570-1.

Van Keer J, Van Keer K, Van Calster J, Derdelinckx I. More than meets the eye: Klebsiella pneumoniae invasive liver abscess syndrome presenting with endophthalmitis. J Emerg Med. 2017;52(6):e221-e3. doi: 10.1016/j.jemermed.2017.01.043.

Tian LT, Yao K, Zhang XY, Zhang ZD, Liang YJ, Yin DL, et al. Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clin Microbiol Infect. 2012;18(9):E314-30. doi: 10.1111/j.1469-0691.2012.03912.x.




DOI: http://dx.doi.org/10.14748/ssm.v49i4.4072

Refbacks

Article Tools
Email this article (Login required)
About The Authors

Atanas Iliev Lisnichkov
Medical University of Varna
Bulgaria

Second Surgery Clinic, University Hospital St. Marina - Varna; Department of Surgery, Medical University of Varna

Milena Bozhkova
Medical University of Varna

Microbiological Laboratory - University Hospital St. Marina - Varna; Department of Microbiology and Virusology, Medical University of Varna

Temenuga Stoeva
Medical University of Varna

Microbiological Laboratory - University Hospital St. Marina - Varna; Department of Microbiology and Virusology, Medical University of Varna

Vassil Bozhkov
Medical University of Varna

Second Surgery Clinic, University Hospital St. Marina - Varna; Department of Surgery, Medical University of Varna

Ilko Plachkov
Medical University of Varna

Second Surgery Clinic, University Hospital St. Marina - Varna; Department of Surgery, Medical University of Varna

Plamen Chernopolski
Medical University of Varna

Second Surgery Clinic, University Hospital St. Marina - Varna; Department of Surgery, Medical University of Varna

Todor Ivanov
Medical University of Varna

Second Surgery Clinic, University Hospital St. Marina - Varna; Department of Surgery, Medical University of Varna

Gergana Nedelcheva
Medical University of Varna

Microbiological Laboratory - University Hospital St. Marina - Varna; Department of Microbiology and Virusology, Medical University of Varna

Viktoriya Snegarova
Medical University of Varna

Microbiological Laboratory - University Hospital St. Marina - Varna; Department of Microbiology and Virusology, Medical University of Varna

Dobromira Dimitrova
Medical University of Varna

Microbiological Laboratory - University Hospital St. Marina - Varna; Department of Microbiology and Virusology, Medical University of Varna

Rossen Madjov
Medical University of Varna

Second Surgery Clinic, University Hospital St. Marina - Varna; Department of Surgery, Medical University of Varna

Font Size


|